Skip to content
The Policy VaultThe Policy Vault

Egaten (triclabendazole)CareFirst (Caremark)

fascioliasis

Initial criteria

  • Infection confirmed by diagnostic or laboratory test
  • Patient age ≥ 6 years
  • Request is for a quantity up to 32 tablets OR a second day or course of therapy (first course administered within the past year)

Approval duration

1 month